RAB22A and osteosarcoma: of Rab22a-NeoF1 conjugated to the cell-penetrating peptide iRGD, which was able to prevent lung metastasis of cancer cells positive for RAB22A-NeoF1 in the orthotopic osteosarcoma metastasis model.6 Notably, the 1–10 a.a.